PLK4 and melanoma: While elevated PLK4 levels do not always correlate with centrosome amplification, pharmacological inhibition of PLK4 using centrinone B was shown to suppress proliferation and induced apoptosis in melanoma cells, highlighting PLK4 as a viable therapeutic target for melanoma management [11].